Physician profile
Mike David
NPI 1013469295
$5,401.69
in general payments reported to CMS, 2019-2025
20 companies · $1,912 in 2025
The $1,912 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $667 · 2022: $707 · 2023: $995 · 2024: $1,121 · 2025: $1,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,898 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,897.58 |
| Education | $130.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,412.06 | 2021-2025 | |
| Pfizer INC. | $691.41 | 2021-2025 | |
| Arcutis Biotherapeutics, INC. | $519.09 | 2023-2025 | Zoryve |
| Janssen Biotech, INC. | $448.26 | 2022-2025 | Tremfya, Simponi Aria, Simponi |
| Genzyme Corporation | $427.40 | 2022-2025 | |
| Amgen INC. | $338.22 | 2021-2025 | Otezla, Otezla |
| Leo Pharma INC. | $317.29 | 2021-2025 | Adbry, Anzupgo |
| Incyte Corporation | $268.79 | 2022-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $257.91 | 2023-2025 | Sotyktu |
| Dermavant Sciences, INC. | $133.51 | 2023-2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $119.99 | 2024-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $108.17 | 2021-2025 | |
| Cipher Pharmaceuticals US LLC | $75.10 | 2025 | Natroba, Spinosad |
| Verrica Pharmaceuticals INC. | $73.48 | 2024 | Ycanth |
| Lilly USA, LLC | $64.04 | 2022-2024 | Taltz, Olumiant |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $56.08 | 2021-2025 | Cabtreo |
| Organon LLC | $45.00 | 2025 | |
| Ucb, INC. | $18.06 | 2024 | Bimzelx |
| Strata Skin Sciences, INC. | $14.25 | 2025 | Xtrac |
| Journey Medical Corporation | $13.58 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mike David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.